Annual EBIT:
-$3.94B-$41.00M(-1.05%)Summary
- As of today, MRNA annual earnings before interest & taxes is -$3.94 billion, with the most recent change of -$41.00 million (-1.05%) on December 31, 2024.
- During the last 3 years, MRNA annual EBIT has fallen by -$17.24 billion (-129.67%).
- MRNA annual EBIT is now -129.67% below its all-time high of $13.30 billion, reached on December 31, 2021.
Performance
MRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$260.00M+$647.00M(+71.33%)Summary
- As of today, MRNA quarterly earnings before interest & taxes is -$260.00 million, with the most recent change of +$647.00 million (+71.33%) on September 30, 2025.
- Over the past year, MRNA quarterly EBIT has dropped by -$190.00 million (-271.43%).
- MRNA quarterly EBIT is now -104.87% below its all-time high of $5.34 billion, reached on December 31, 2021.
Performance
MRNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$3.46B-$190.00M(-5.81%)Summary
- As of today, MRNA TTM earnings before interest & taxes is -$3.46 billion, with the most recent change of -$190.00 million (-5.81%) on September 30, 2025.
- Over the past year, MRNA TTM EBIT has dropped by -$762.00 million (-28.21%).
- MRNA TTM EBIT is now -121.41% below its all-time high of $16.17 billion, reached on March 31, 2022.
Performance
MRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MRNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -1.1% | -271.4% | -28.2% |
| 3Y3 Years | -129.7% | -123.3% | -126.5% |
| 5Y5 Years | -622.5% | -10.6% | -459.8% |
MRNA EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -129.7% | at low | -117.1% | +87.1% | -126.5% | +32.7% |
| 5Y | 5-Year | -129.7% | at low | -104.9% | +87.1% | -121.4% | +32.7% |
| All-Time | All-Time | -129.7% | at low | -104.9% | +87.1% | -121.4% | +32.7% |
MRNA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$260.00M(+71.3%) | -$3.46B(-5.8%) |
| Jun 2025 | - | -$907.00M(+13.6%) | -$3.27B(+12.2%) |
| Mar 2025 | - | -$1.05B(+15.7%) | -$3.73B(+5.5%) |
| Dec 2024 | -$3.94B(-1.1%) | -$1.25B(-1680.0%) | -$3.94B(-46.1%) |
| Sep 2024 | - | -$70.00M(+94.9%) | -$2.70B(+41.8%) |
| Jun 2024 | - | -$1.36B(-7.7%) | -$4.64B(+9.8%) |
| Mar 2024 | - | -$1.27B(>-9900.0%) | -$5.15B(-21.4%) |
| Dec 2023 | -$3.90B(-140.6%) | -$2.00M(+99.9%) | -$4.24B(-56.0%) |
| Sep 2023 | - | -$2.01B(-7.8%) | -$2.72B(-761.1%) |
| Jun 2023 | - | -$1.87B(-421.5%) | $411.00M(-91.2%) |
| Mar 2023 | - | -$358.00M(-123.6%) | $4.70B(-49.3%) |
| Dec 2022 | $9.60B(-27.8%) | $1.52B(+36.2%) | $9.27B(-29.2%) |
| Sep 2022 | - | $1.12B(-53.8%) | $13.09B(-15.7%) |
| Jun 2022 | - | $2.42B(-42.6%) | $15.53B(-4.0%) |
| Mar 2022 | - | $4.21B(-21.1%) | $16.17B(+22.3%) |
| Dec 2021 | $13.30B(+1842.6%) | $5.34B(+50.1%) | $13.23B(+73.8%) |
| Sep 2021 | - | $3.56B(+16.2%) | $7.61B(+99.4%) |
| Jun 2021 | - | $3.06B(+141.9%) | $3.82B(+502.5%) |
| Mar 2021 | - | $1.27B(+560.3%) | $633.72M(+183.0%) |
| Dec 2020 | -$763.00M(-39.7%) | -$275.04M(-17.0%) | -$763.14M(-23.4%) |
| Sep 2020 | - | -$235.12M(-92.5%) | -$618.66M(-20.3%) |
| Jun 2020 | - | -$122.13M(+6.7%) | -$514.31M(+4.0%) |
| Mar 2020 | - | -$130.86M(-0.2%) | -$535.89M(+2.0%) |
| Dec 2019 | -$546.00M(-43.2%) | -$130.56M(+0.2%) | -$546.67M(+3.9%) |
| Sep 2019 | - | -$130.76M(+9.0%) | -$569.14M(-8.6%) |
| Jun 2019 | - | -$143.71M(-1.5%) | -$524.20M(-9.8%) |
| Mar 2019 | - | -$141.64M(+7.4%) | -$477.50M(-15.5%) |
| Dec 2018 | -$381.31M(-49.0%) | -$153.03M(-78.3%) | -$413.27M(-36.8%) |
| Sep 2018 | - | -$85.82M(+11.5%) | -$302.06M(-6.3%) |
| Jun 2018 | - | -$97.02M(-25.3%) | -$284.12M(-50.9%) |
| Mar 2018 | - | -$77.40M(-85.0%) | -$188.26M(-68.2%) |
| Dec 2017 | -$255.86M(-14.3%) | -$41.83M(+38.4%) | -$111.92M(-58.6%) |
| Sep 2017 | - | -$67.87M(-5773.1%) | -$70.59M(-2406.6%) |
| Jun 2017 | - | -$1.16M(-8.0%) | -$2.82M(-57.4%) |
| Mar 2017 | - | -$1.07M(-117.3%) | -$1.79M(-114.8%) |
| Dec 2016 | -$223.77M(-6803.7%) | - | - |
| Dec 2016 | - | -$492.50K(-404.1%) | -$832.80K(-113.1%) |
| Sep 2016 | - | -$97.70K(+23.9%) | $6.37M(+17.2%) |
| Jun 2016 | - | -$128.40K(-12.4%) | $5.43M(+19.7%) |
| Mar 2016 | - | -$114.20K(-101.7%) | $4.54M(+36.0%) |
| Dec 2015 | $3.34M(+161.0%) | $6.71M(+749.9%) | $3.34M(+37.2%) |
| Sep 2015 | - | -$1.03M(-1.0%) | $2.43M(+166.5%) |
| Jun 2015 | - | -$1.02M(+22.3%) | -$3.66M(-384.7%) |
| Mar 2015 | - | -$1.31M(-122.7%) | $1.28M(+123.5%) |
| Dec 2014 | -$5.47M(-302.0%) | $5.80M(+181.5%) | -$5.47M(+58.6%) |
| Sep 2014 | - | -$7.12M(-281.7%) | -$13.21M(-88.7%) |
| Jun 2014 | - | $3.92M(+148.6%) | -$7.00M(+37.0%) |
| Mar 2014 | - | -$8.07M(-316.0%) | -$11.11M(-593.0%) |
| Dec 2013 | -$1.36M(+82.5%) | -$1.94M(-112.7%) | -$1.60M(+63.8%) |
| Sep 2013 | - | -$912.00K(-390.3%) | -$4.43M(+12.6%) |
| Jun 2013 | - | -$186.00K(-113.0%) | -$5.06M(-107.0%) |
| Mar 2013 | - | $1.44M(+130.1%) | -$2.45M(+68.6%) |
| Dec 2012 | -$7.79M(+72.5%) | -$4.76M(-207.5%) | -$7.79M(+60.4%) |
| Sep 2012 | - | -$1.55M(-163.7%) | -$19.67M(+12.6%) |
| Jun 2012 | - | $2.43M(+162.2%) | -$22.51M(+25.8%) |
| Mar 2012 | - | -$3.91M(+76.5%) | -$30.33M(+3.6%) |
| Dec 2011 | -$28.28M(-13.5%) | -$16.64M(-279.4%) | -$31.46M(-61.4%) |
| Sep 2011 | - | -$4.39M(+18.6%) | -$19.50M(+15.6%) |
| Jun 2011 | - | -$5.39M(-7.0%) | -$23.09M(-8.6%) |
| Mar 2011 | - | -$5.04M(-7.7%) | -$21.25M(+4.2%) |
| Dec 2010 | -$24.93M(-143.5%) | -$4.68M(+41.4%) | -$22.19M(-6.7%) |
| Sep 2010 | - | -$7.98M(-124.3%) | -$20.80M(-4.9%) |
| Jun 2010 | - | -$3.56M(+40.5%) | -$19.83M(+16.1%) |
| Mar 2010 | - | -$5.97M(-81.7%) | -$23.64M(-142.8%) |
| Dec 2009 | -$10.24M | -$3.29M(+53.1%) | -$9.73M(+47.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$7.01M(+4.8%) | -$18.50M(+13.0%) |
| Jun 2009 | - | -$7.36M(-192.9%) | -$21.26M(+24.4%) |
| Mar 2009 | - | $7.93M(+165.8%) | -$28.13M(+44.5%) |
| Dec 2008 | -$50.69M(+7.1%) | -$12.05M(-23.2%) | -$50.69M(+0.5%) |
| Sep 2008 | - | -$9.78M(+31.3%) | -$50.95M(+12.4%) |
| Jun 2008 | - | -$14.23M(+2.7%) | -$58.13M(-2.1%) |
| Mar 2008 | - | -$14.63M(-18.8%) | -$56.93M(-4.4%) |
| Dec 2007 | -$54.53M(-86.0%) | -$12.31M(+27.4%) | -$54.53M(-2.3%) |
| Sep 2007 | - | -$16.97M(-30.2%) | -$53.32M(-19.1%) |
| Jun 2007 | - | -$13.03M(-6.6%) | -$44.75M(-36.1%) |
| Mar 2007 | - | -$12.23M(-10.2%) | -$32.88M(-12.1%) |
| Dec 2006 | -$29.32M(+13.3%) | -$11.10M(-32.2%) | -$29.32M(-5.8%) |
| Sep 2006 | - | -$8.40M(-628.4%) | -$27.70M(+2.9%) |
| Jun 2006 | - | -$1.15M(+86.7%) | -$28.55M(+20.9%) |
| Mar 2006 | - | -$8.67M(+8.6%) | -$36.08M(-6.8%) |
| Dec 2005 | -$33.80M(-18.6%) | -$9.48M(-2.7%) | -$33.80M(-11.8%) |
| Sep 2005 | - | -$9.24M(-6.3%) | -$30.24M(-6.0%) |
| Jun 2005 | - | -$8.69M(-36.1%) | -$28.52M(-4.6%) |
| Mar 2005 | - | -$6.39M(-7.9%) | -$27.27M(+4.3%) |
| Dec 2004 | -$28.49M(-358.7%) | -$5.92M(+21.3%) | -$28.49M(+0.0%) |
| Sep 2004 | - | -$7.53M(-1.2%) | -$28.50M(-4.7%) |
| Jun 2004 | - | -$7.44M(+2.1%) | -$27.22M(-147.9%) |
| Mar 2004 | - | -$7.60M(-28.1%) | -$10.98M(-76.8%) |
| Dec 2003 | -$6.21M(+52.2%) | -$5.93M(+5.0%) | -$6.21M(-15.5%) |
| Sep 2003 | - | -$6.25M(-171.0%) | -$5.38M(-106.1%) |
| Jun 2003 | - | $8.80M(+410.7%) | -$2.61M(+79.9%) |
| Mar 2003 | - | -$2.83M(+44.5%) | -$12.96M(+0.2%) |
| Dec 2002 | -$12.99M(-36.0%) | -$5.10M(-46.6%) | -$12.99M(-18.3%) |
| Sep 2002 | - | -$3.48M(-124.1%) | -$10.98M(-16.9%) |
| Jun 2002 | - | -$1.55M(+45.8%) | -$9.40M(+6.1%) |
| Mar 2002 | - | -$2.86M(+7.4%) | -$10.01M(-4.8%) |
| Dec 2001 | -$9.55M(+7.6%) | -$3.09M(-63.2%) | -$9.55M(+5.9%) |
| Sep 2001 | - | -$1.89M(+12.4%) | -$10.15M(-0.5%) |
| Jun 2001 | - | -$2.16M(+10.0%) | -$10.11M(+2.5%) |
| Mar 2001 | - | -$2.40M(+35.0%) | -$10.36M(-0.3%) |
| Dec 2000 | -$10.34M(-9.3%) | -$3.69M(-99.9%) | -$10.34M(+2.4%) |
| Sep 2000 | - | -$1.85M(+23.5%) | -$10.59M(+1.1%) |
| Jun 2000 | - | -$2.42M(-1.8%) | -$10.71M(-7.2%) |
| Mar 2000 | - | -$2.38M(+39.9%) | -$9.99M(+0.2%) |
| Dec 1999 | -$9.45M(-301.9%) | -$3.95M(-101.5%) | -$10.02M(-17.6%) |
| Sep 1999 | - | -$1.96M(-15.4%) | -$8.51M(-24.3%) |
| Jun 1999 | - | -$1.70M(+29.2%) | -$6.85M(-28.0%) |
| Mar 1999 | - | -$2.40M(+2.1%) | -$5.35M(-69.8%) |
| Dec 1998 | -$2.35M(+60.8%) | -$2.45M(-717.3%) | -$3.15M(-1.7%) |
| Sep 1998 | - | -$300.00K(-50.0%) | -$3.10M(+31.1%) |
| Jun 1998 | - | -$200.00K(0.0%) | -$4.50M(+19.6%) |
| Mar 1998 | - | -$200.00K(+91.7%) | -$5.60M(+8.2%) |
| Dec 1997 | -$6.00M(-1100.0%) | -$2.40M(-41.2%) | -$6.10M(-64.9%) |
| Sep 1997 | - | -$1.70M(-30.8%) | -$3.70M(-85.0%) |
| Jun 1997 | - | -$1.30M(-85.7%) | -$2.00M(-300.0%) |
| Mar 1997 | - | -$700.00K(>-9900.0%) | -$500.00K(>-9900.0%) |
| Dec 1996 | -$500.00K(-400.0%) | - | - |
| Sep 1996 | - | $0.00(-100.0%) | $0.00(+100.0%) |
| Jun 1996 | -$100.00K(0.0%) | $200.00K(+100.0%) | -$100.00K(+66.7%) |
| Mar 1996 | - | $100.00K(+133.3%) | -$300.00K(+25.0%) |
| Dec 1995 | - | -$300.00K(-200.0%) | -$400.00K(-100.0%) |
| Sep 1995 | - | -$100.00K(>-9900.0%) | -$200.00K(>-9900.0%) |
| Jun 1995 | -$100.00K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(+100.0%) | $100.00K(>+9900.0%) |
| Dec 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1994 | $200.00K | $100.00K(+200.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | -$100.00K(-200.0%) | $100.00K(-50.0%) |
| Dec 1993 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Moderna, Inc.?
- What is Moderna, Inc. annual EBIT year-on-year change?
- What is Moderna, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Moderna, Inc.?
- What is Moderna, Inc. quarterly EBIT year-on-year change?
- What is Moderna, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Moderna, Inc.?
- What is Moderna, Inc. TTM EBIT year-on-year change?
What is Moderna, Inc. annual earnings before interest & taxes?
The current annual EBIT of MRNA is -$3.94B
What is the all-time high annual EBIT for Moderna, Inc.?
Moderna, Inc. all-time high annual earnings before interest & taxes is $13.30B
What is Moderna, Inc. annual EBIT year-on-year change?
Over the past year, MRNA annual earnings before interest & taxes has changed by -$41.00M (-1.05%)
What is Moderna, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of MRNA is -$260.00M
What is the all-time high quarterly EBIT for Moderna, Inc.?
Moderna, Inc. all-time high quarterly earnings before interest & taxes is $5.34B
What is Moderna, Inc. quarterly EBIT year-on-year change?
Over the past year, MRNA quarterly earnings before interest & taxes has changed by -$190.00M (-271.43%)
What is Moderna, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of MRNA is -$3.46B
What is the all-time high TTM EBIT for Moderna, Inc.?
Moderna, Inc. all-time high TTM earnings before interest & taxes is $16.17B
What is Moderna, Inc. TTM EBIT year-on-year change?
Over the past year, MRNA TTM earnings before interest & taxes has changed by -$762.00M (-28.21%)